2025-524165-25-00招募中1 期
First time in human (FTIH) study to investigate the safety and preliminary activity of GSK5533524 alone or in combination in adult participants with advanced solid tumors
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 52
- 试验地点
- 9
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
EU GSK Clinical Trials Call Center
Scientific
Glaxosmithkline Research & Development Limited
研究点 (9)
Loading locations...
相似试验
招募中
1 期
A Study of HDM2006 in Patients With Advanced Solid TumorNCT07377591Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.48
招募中
不适用
A Phase 1/2 Study of KK2430 in Participants with with Hematologic NeoplasmsHematologic NeoplasmsjRCT203126006420
招募中
不适用
A clinical study to evaluate the safety of MF1, a new treatment for Parkinson's disease-related disorders (MF1 Study)Parkinson's diseasejRCT202126000658
招募中
1 期
A first-in-human, phase I, single-center, open-label, dose-escalation trial in healthy volunteers to assess safety, tolerability, and immunogenicity of PANHPVAX, a vaccine targeting human papilloma L2 antigen formulated with cyclic di-AMP2024-511493-67-00Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts45
招募中
1 期
First-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of VTX-PID in healthy male volunteers2023-503892-83-00Vivet Therapeutics35